doi:10.3109/07420528.2015.1073158
A model of diabetic neuropathy caused by streptozotocin in rats has shown the neuroprotective properties of GLP-1RA semaglutide by reducing inflammation and oxidative stress by inhibiting the activity of astrocytes and microglia [32]
Eli Lilly (LLY) unveiled its newest manufacturing plant in Concord, N.C., Friday, which the company says will help relieve manufacturing bottlenecks for GLP-1 drugs
Condiciones mdicas coexistentes: La presencia de enfermedad cardiovascular, enfermedad renal crnica, retinopata diabtica, o antecedentes de pancreatitis puede influir tanto en la necesidad como en la seguridad del uso prolongado
Semaglutide also has a positive effect on blood lipid profile, decreases systolic blood pressure, and reduces insulin resistance
The presence of multiple cardiovascular risk factors strengthens the indication for pharmacotherapy-assisted weight management